Aplastic anemia differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
mNo edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Aplastic anemia}} | {{Aplastic anemia}} | ||
{{CMG}} {{AE}} Aric Hall, M.D., Beth Israel Deaconess Medical Center, Boston, MA [mailto:achall@bidmc.harvard.edu] | |||
==Overview== | ==Overview== | ||
The primary diagnostic dilemma is differentiating aplastic anemia from a hypocellular [[myelodysplastic syndrome]]. | The primary diagnostic dilemma is differentiating aplastic anemia from a hypocellular [[myelodysplastic syndrome]]. | ||
==Differentiating Aplastic anemia from other Diseases== | ==Differentiating Aplastic anemia from other Diseases== | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
Revision as of 18:25, 16 June 2016
|
Aplastic anemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Aplastic anemia differential diagnosis On the Web |
|
American Roentgen Ray Society Images of Aplastic anemia differential diagnosis |
|
Risk calculators and risk factors for Aplastic anemia differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aric Hall, M.D., Beth Israel Deaconess Medical Center, Boston, MA [2]
Overview
The primary diagnostic dilemma is differentiating aplastic anemia from a hypocellular myelodysplastic syndrome.